Rapid establishment of a COVID-19 convalescent plasma program in a regional health care delivery network.

Background: COVID-19 convalescent plasma (CCP) represents an appealing approach to the treatment of patients with infections due to SARS-CoV-2. We endeavored to quickly establish a sustainable CCP transfusion program for a regional network of health care facilities.

Study Design And Methods: A regional collaborative group was activated to address the issues necessary to implementing a CCP transfusion program and making the program sustainable.